Novavax | DEFA14A: Others
Apr 29 08:03 ET
Novavax | DEF 14A: Definitive information statements
Apr 29 07:57 ET
Novavax | 8-K: Current report
Apr 26 16:39 ET
Novavax | 8-K: Confidential Settlement Agreements and Release Agreements
Mar 26 16:07 ET
Novavax | 8-K: Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Feb 28 08:12 ET
Novavax | 8-K: Entry into a Termination and Settlement Agreement
Feb 22 06:11 ET
Novavax | 8-K: Current report
Jan 31 08:01 ET
Novavax | 8-K: Results of Operations and Financial Condition
Jan 8 00:00 ET
Novavax | 8-K: Sothinathan Sinnathurai files alleged securities class action lawsuit against Novavax and certain members of the company's senior management
Dec 5, 2023 08:45 ET
Novavax | 8-K: Novavax Executive Leadership Team Membership Changes
Nov 17, 2023 16:36 ET
Novavax | 8-K: Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
Nov 9, 2023 08:05 ET
Novavax | 8-K/A: Poll Results of 2023 Annual Meeting of Shareholders
Nov 2, 2023 17:00 ET
Novavax | 8-K: Current report
Oct 3, 2023 16:59 ET
Novavax | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 8, 2023 16:06 ET
Novavax | 8-K: Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
Aug 8, 2023 08:05 ET
Novavax | 8-K: AT MARKET ISSUANCE SALES AGREEMENT
Aug 8, 2023 07:56 ET
Novavax | 8-K: SECURITIES SUBSCRIPTION AGREEMENT
Aug 8, 2023 07:20 ET
Novavax | 8-K: NOVAVAX, INC. 2015 STOCK INCENTIVE PLAN AMENDED AND RESTATED MARCH 30, 2023
Jul 11, 2023 17:12 ET
Novavax | DEFA14A: Others
Jul 7, 2023 16:30 ET
Novavax | 8-K: Entry into a Material Definitive Agreement
Jul 7, 2023 16:01 ET
No Data
No Data